|Exclusive Science News Videos from ACC.13|
ACC.13 Late Breaking Clinical Trials IV - Session 303
Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis PARTNER 1A
Vinod Thourani, MD, Emory University
MASS COMM - A Randomized Trial to Compare Percutaneous Coronary Intervention between Massachusetts Hospitals With Cardiac Surgery On-Site and Community Hospitals Without Cardiac Surgery On-Site
Alice Jacobs, MD, Boston University School of Medicine
Presentation slides | Summary slide
The German Off-Pump Coronary Artery Bypass Grafting in Elderly Patients Study
Anno Diegeler, MD, PhD, Chefarzt bei Herz-und Gefäßklinik Bad Neustadt
CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study, Results at 1 Year
Dr. Andre Lamy, McMaster University, Hamilton, Ontario
ACC.13 Late Breaking Clinical Trials - Session 314
10:45 a.m.–12:15 p.m.
The ASTRONAUT Study: Aliskiren Trial on Acute Heart Failure Outcomes
Mihai Gheorghiad, MD, Northwestern University
Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure (RELAX) Trial
Margaret Redfield, MD, Mayo Clinic
- In 2010, in the United States, 219,000 patients underwent a total of 397,000 coronary artery bypass procedures.
- Of that, coronary artery bypass procedures were performed on 164,000 men and 55,000 women – 58% over the age of 65.
- Risk-adjusted mortality for coronary artery bypass has declined significantly over the past decade.